209 related articles for article (PubMed ID: 14724679)
41. Hydrogen peroxide as an irrigation solution in arthroplasty - a potential contributing factor to the development of aseptic loosening.
Guerin S; Harty J; Thompson N; Bryan K
Med Hypotheses; 2006; 66(6):1142-5. PubMed ID: 16481122
[TBL] [Abstract][Full Text] [Related]
42. Plasma cytokines as markers of aseptic prosthesis loosening.
Hundrić-Haspl Z; Pecina M; Haspl M; Tomicic M; Jukic I
Clin Orthop Relat Res; 2006 Dec; 453():299-304. PubMed ID: 16906105
[TBL] [Abstract][Full Text] [Related]
43. RANK, RANKL and OPG in inflammatory arthritis and periprosthetic osteolysis.
Ritchlin CT; Schwarz EM; O'Keefe RJ; Looney RJ
J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):276-84. PubMed ID: 15615495
[TBL] [Abstract][Full Text] [Related]
44. Pathology of the bone-implant interfaces.
al-Saffar N; Revell PA
J Long Term Eff Med Implants; 1999; 9(4):319-47. PubMed ID: 10847971
[TBL] [Abstract][Full Text] [Related]
45. Effect of zoledronate on bone quality in the treatment of aseptic loosening of hip arthroplasty in the dog.
Wise LM; Waldman SD; Kasra M; Cheung R; Binnington A; Kandel RA; White LM; Grynpas MD
Calcif Tissue Int; 2005 Dec; 77(6):367-75. PubMed ID: 16362454
[TBL] [Abstract][Full Text] [Related]
46. Basic scientific considerations in total disc arthroplasty.
Cunningham BW
Spine J; 2004; 4(6 Suppl):219S-230S. PubMed ID: 15541670
[TBL] [Abstract][Full Text] [Related]
47. Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis.
Yang SY; Wu B; Mayton L; Mukherjee P; Robbins PD; Evans CH; Wooley PH
Gene Ther; 2004 Mar; 11(5):483-91. PubMed ID: 14724688
[TBL] [Abstract][Full Text] [Related]
48. Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty.
Beraudi A; Stea S; Cremonini S; Visentin M; Toni A
Artif Organs; 2009 Jul; 33(7):538-43. PubMed ID: 19566730
[TBL] [Abstract][Full Text] [Related]
49. Murine model of prosthesis failure for the long-term study of aseptic loosening.
Yang SY; Yu H; Gong W; Wu B; Mayton L; Costello R; Wooley PH
J Orthop Res; 2007 May; 25(5):603-11. PubMed ID: 17278141
[TBL] [Abstract][Full Text] [Related]
50. Effect of cyclic mechanical stretch and titanium particles on prostaglandin E2 production by human macrophages in vitro.
Fujishiro T; Nishikawa T; Shibanuma N; Akisue T; Takikawa S; Yamamoto T; Yoshiya S; Kurosaka M
J Biomed Mater Res A; 2004 Mar; 68(3):531-6. PubMed ID: 14762933
[TBL] [Abstract][Full Text] [Related]
51. Particle Disease: A Current Review of the Biological Mechanisms in Periprosthetic Osteolysis After Hip Arthroplasty.
Sukur E; Akman YE; Ozturkmen Y; Kucukdurmaz F
Open Orthop J; 2016; 10():241-51. PubMed ID: 27499822
[TBL] [Abstract][Full Text] [Related]
52. Are biologic treatments a potential approach to wear- and corrosion-related problems?
Smith RL; Schwarz EM
Clin Orthop Relat Res; 2014 Dec; 472(12):3740-6. PubMed ID: 24993143
[TBL] [Abstract][Full Text] [Related]
53. PMMA particles and pressure--a study of the osteolytic properties of two agents proposed to cause prosthetic loosening.
Skoglund B; Aspenberg P
J Orthop Res; 2003 Mar; 21(2):196-201. PubMed ID: 12568949
[TBL] [Abstract][Full Text] [Related]
54. The pathology of total joint arthroplasty.II. Mechanisms of implant failure.
Bauer TW; Schils J
Skeletal Radiol; 1999 Sep; 28(9):483-97. PubMed ID: 10525792
[TBL] [Abstract][Full Text] [Related]
55. Report: Osteocyte enhancement function of bisphosphonates in prosthetic replacement.
Yang J; Wang S; Meng Q; Sun Y; Ran AF
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1167-9. PubMed ID: 26051741
[TBL] [Abstract][Full Text] [Related]
56. Potential use of erythromycin to prevent and treat prosthetic failure.
Zhang P; Qin L
J Clin Pharmacol; 2010 Aug; 50(8):858-60. PubMed ID: 20150525
[TBL] [Abstract][Full Text] [Related]
57. Metal ions as inflammatory initiators of osteolysis.
Magone K; Luckenbill D; Goswami T
Arch Orthop Trauma Surg; 2015 May; 135(5):683-95. PubMed ID: 25795427
[TBL] [Abstract][Full Text] [Related]
58. Presence of interleukin-17C in the tissue around aseptic loosened implants.
Hou C; Zhang Y; Yu S; Li Z; Zhai Q; Li Z; Zhang X; Xiao J; Sheng P
Int Orthop; 2013 May; 37(5):953-9. PubMed ID: 23474800
[TBL] [Abstract][Full Text] [Related]
59. Innate immune reactions in septic and aseptic osteolysis around hip implants.
Pajarinen J; Jamsen E; Konttinen YT; Goodman SB
J Long Term Eff Med Implants; 2014; 24(4):283-96. PubMed ID: 25747031
[TBL] [Abstract][Full Text] [Related]
60. Biologic Responses to Orthopedic Implants: Innate and Adaptive Immune Responses to Implant Debris.
Hallab NJ
Spine (Phila Pa 1976); 2016 Apr; 41 Suppl 7():S30-1. PubMed ID: 27015070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
